IDFC Midcap Fund
An open ended equity scheme predominantly investing in mid cap stocks
IDFC Midcap Fund
An open ended fund of fund scheme investing in units/shares of overseas Mutual Fund Scheme
(/s) / Exchange Traded Fund (/s) investing in US Equity securities
|
|
|
|
|
|
About the Fund: The Fund seeks to generate long term capital appreciation by investing predominantly in equities and equity linked securities of mid cap segment.
Category: Midcap
: ₹ 610.03 Crores
AUM or assets under management refers to the recent / updated cumulative market value of investments managed by a mutual fund or any investment firm.
: ₹ 616.97 Crores
AUM or assets under management refers to the recent / updated cumulative market value of investments managed by a mutual fund or any investment firm.
:
An employee of the asset management company such as a mutual fund or life insurer, who manages investments of the scheme. He is usually part of a larger team of fund managers and research analysts.
Mr. Harshal Joshi (debt portion)
Ms. Nishita Doshi will be managing overseas investment portion of the scheme.
| Total Expense Ratio | |
| Regular | 2.51% |
| Direct | 0.76% |
SIP (Minimum Amount): ₹ 100/- and in multiples of Re. 1 thereafter
SIP Frequency: Monthly
SIP Dates (Monthly): Investor may choose any day of the month except 29th, 30th and 31st as the date of instalment.
Investment Objective: Click here
Minimum Investment Amount : Rs 5,000/- and any amount thereafter
Option Available: Growth, IDCW@ - (Payout of Income Distribution cum capital withdrawal option and in case the amount of Income Distribution cum capital withdrawal payable to the Unitholder is ₹ 100/- or less under a Folio, the same will be compulsorily reinvested in the Scheme.)
:
Exit load is charged at the time an investor redeems the units of a mutual fund. The exit load is deducted from the prevailing NAV at the time of redemption. For instance, if the NAV is ₹ 100 and the exit load is 1%, the redemption price would be ₹ 99 per unit.
If redeemed/switched out after 1 year from the date of allotment - Nil
NAV (₹) as on November 30, 2022
| Regular Plan | Growth | 10.04 |
| Regular Plan | IDCW@ | 10.04 |
Portfolio Beta, Standard Deviation, R Squared, Sharpe Ratio and Tracking Error of the Scheme is not computed owing to the short time frame (<3years) since launch of the Scheme
| Name | % of NAV |
| Equity and Equity related Instruments | 80.61% |
| Banks | 11.19% |
| oICICI Bank | 5.14% |
| oAxis Bank | 3.15% |
| oThe Federal Bank | 2.90% |
| Chemicals & Petrochemicals | 10.53% |
| oTata Chemicals | 3.37% |
| Navin Fluorine International | 2.63% |
| Vinati Organics | 2.43% |
| Atul | 1.99% |
| Fine Organic Industries | 0.10% |
| Industrial Products | 9.65% |
| oCummins India | 3.15% |
| Astral | 2.26% |
| APL Apollo Tubes | 2.18% |
| Bharat Forge | 1.50% |
| Supreme Industries | 0.55% |
| Auto Components | 6.91% |
| oUNO Minda | 3.01% |
| Schaeffler India | 1.86% |
| Bosch | 1.07% |
| Sundram Fasteners | 0.97% |
| Retailing | 5.45% |
| oTrent | 2.96% |
| Aditya Birla Fashion and Retail | 2.49% |
| Automobiles | 5.42% |
| oTVS Motor Company | 3.63% |
| Mahindra & Mahindra | 1.79% |
| IT - Software | 4.58% |
| oPersistent Systems | 3.06% |
| Infosys | 1.52% |
| Leisure Services | 4.15% |
| The Indian Hotels Company | 2.46% |
| Jubilant Foodworks | 1.70% |
| Consumer Durables | 4.11% |
| Kajaria Ceramics | 2.33% |
| Metro Brands | 1.78% |
| Electrical Equipment | 3.85% |
| CG Power and Industrial Solutions | 2.20% |
| Thermax | 1.65% |
| Pharmaceuticals & Biotechnology | 3.51% |
| Abbott India | 2.09% |
| IPCA Laboratories | 1.42% |
| Beverages | 2.73% |
| oUnited Breweries | 2.73% |
| Telecom - Services | 2.14% |
| Tata Communications | 2.14% |
| Fertilizers & Agrochemicals | 1.95% |
| Coromandel International | 1.95% |
| Diversified | 1.21% |
| 3M India | 1.21% |
| Capital Markets | 1.16% |
| ICICI Securities | 1.16% |
| Textiles & Apparels | 1.06% |
| K.P.R. Mill | 1.06% |
| Finance | 1.00% |
| M&M Financial Services | 1.00% |
| Healthcare Services | 0.01% |
| Krishna Institute of Medical Sciences | 0.01% |
| Net Cash and Cash Equivalent | 19.39% |
| Grand Total | 100.00% |
| oTop 10 Equity Holdings |
Scheme risk-o-meter
Investors understand that their principal will be at Very High risk
This product is suitable for investors who are seeking*
- To create wealth over a long term.
- Investment in a portfolio of equity and equity related securities of mid cap companies.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Benchmark risk-o-meter
S&P BSE 150 Midcap Index
Performance, SIP & other parameters are not disclosed as fund has not completed 6 months.
Click here for other funds managed by the fund manager and refer to the respective fund pages
